How semaglutide causes weight loss — and why it works differently from dieting alone

You've reduced your portions, stuck to the plan, and still the scale barely moves

This is where a lot of people find themselves before they start researching semaglutide. The frustrating truth is that sustained calorie reduction triggers hormonal changes that actively increase hunger and lower your metabolic rate — the body treating the deficit as a threat rather than a goal. If you're curious about why semaglutide causes weight loss rather than simply suppressing appetite the way a diet does, the answer lies in how it interacts with the hormonal systems that regulate hunger in the first place. That sustained signalling is what makes it effective as a weekly injection rather than something needing constant dosing.

GLP-1 (glucagon-like peptide-1) is a hormone your gut already releases after meals. Its job is to signal to the brain that food has arrived, slow gastric emptying, and moderate blood sugar. Semaglutide is a synthetic molecule that binds to the same receptors GLP-1 uses, but it stays active in the body far longer than the natural hormone does. That sustained signalling is what makes it effective as a weekly injection rather than something needing constant dosing. You can read the full patient-level overview on the NHS semaglutide medicines page, which covers how the medicine works alongside its licensed uses.

Across the semaglutide treatments available in the UK, this same mechanism is at the core, whether the format is an injection or the newer oral tablet.

What semaglutide actually does inside the body, step by step

Start with the brain. Semaglutide crosses into the hypothalamus and brainstem, both areas involved in regulating how hungry or full you feel. By activating GLP-1 receptors there, it turns down the appetite signal. People on semaglutide often describe thinking about food less, feeling satisfied with smaller amounts, and losing the pull of cravings, particularly for calorie-dense foods. That shift is physiological, not motivational.

At the same time, gastric emptying slows. Food leaving the stomach more gradually means blood sugar rises more steadily after a meal, and the physical sense of fullness extends. For many people, this is what they notice first: a meal they'd have finished easily before now satisfies them halfway through.

There's also an effect on the liver's glucose output, which matters particularly for people with type 2 diabetes, though the weight-related effects come mainly from the appetite and gastric pathways described above. The STEP 1 trial, published in the New England Journal of Medicine, randomised 1,961 adults with obesity to 2.4mg semaglutide or placebo over 68 weeks alongside lifestyle counselling. The semaglutide group lost an average of around 15% of body weight; the placebo group around 2.4%. That gap reflects what the mechanism delivers when it works consistently.

If you want a deeper look at how semaglutides cause weight loss across the different formulations, that page goes further into the specific biological pathways involved. If you want a deeper look at how Wegovy specifically produces weight loss, that page goes further into the branded formulation's trial programme.

Does semaglutide cause weight loss for everyone who takes it, and are there limits?

The honest answer is: not identically for everyone. Responses vary. Some people lose substantially more than the trial average; some lose less. Factors that influence this include baseline weight, diet quality, activity levels, how well the dose is tolerated as it increases, and how consistently the medicine is taken. The STEP 1 figures are averages across a large group, not a guaranteed individual outcome.

The licensed dose pathway for Wegovy (semaglutide injection) starts at 0.25mg and increases stepwise, roughly every four weeks, up to a 2.4mg maintenance dose, with a higher 7.2mg dose now approved by the MHRA for suitable adults with a BMI of 30 or above. That titration schedule exists so the body adjusts gradually; most of the gastrointestinal side effects (nausea, loose stools, indigestion) are most noticeable at the start or after an increase and tend to ease over days to a few weeks. If you're starting at the beginning of the titration schedule, our guide to the 0.1 ml semaglutide starting dose explains what to expect at that initial stage.

Semaglutide is not a short-term fix. NICE's recommendation for semaglutide under appraisal TA875 specifies a maximum of two years of treatment within a specialist weight management service on the NHS. Private treatment follows the licensed terms set out in the SmPC, and a prescriber reviews whether continuing is appropriate at each stage. If less than 5% of body weight has been lost after six months at the maintenance dose, carrying on would normally be reviewed.

It's also worth knowing that semaglutide is currently licensed for weight management as Wegovy; Ozempic is the same molecule but licensed for type 2 diabetes and should not be used interchangeably for weight loss. You can explore the full picture of whether Wegovy reliably causes weight loss on a dedicated page.

Practical things worth knowing before a consultation

Semaglutide is a Prescription-Only Medicine. The only legal route to it in the UK is through a clinical assessment by a registered prescriber who decides whether it is appropriate for you. That matters not just as a regulatory point but as a practical one: the prescriber checks for contraindications (including pregnancy, breastfeeding, certain gastrointestinal conditions, a personal or family history of specific thyroid cancers), sets the starting dose correctly, and monitors your progress.

If you're looking at weight loss treatment options more broadly, semaglutide sits alongside tirzepatide (a dual GIP and GLP-1 agonist) as one of two medicines currently licensed in the UK specifically for weight management by injection. A prescriber can help you understand which is more suitable given your medical history.

One small practical note: timing an order so it lands on a Monday is fine, if you order by 12pm on any working day and your consultation is approved, dispatch happens the same day. Whether that's before payday or after, the process is the same, and next-working-day tracked delivery is included.

If you'd like to discuss whether semaglutide is a suitable option for you, our prescribers review consultations the same day they're submitted. Check your eligibility and start your free consultation.